Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 155.50
-3.00 (-1.89%)
Aug 12, 2025, 1:30 PM CST
Accolade Market Cap
TPEX:6712 has a market cap or net worth of 13.62 billion as of August 11, 2025. Its market cap has decreased by -16.41% in one year.
Market Cap
13.62B
Enterprise Value
12.85B
Revenue
948.40M
Ranking
n/a
PE Ratio
31.85
Stock Price
$155.50
Market Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 13.62B, an increase of 167.29%. That is a compound annual growth rate of 15.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 13.88B | -1.93% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | 9.86B | 8.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.18B |
| PharmaEssentia | 166.30B |
| Bora Pharmaceuticals Co., LTD. | 88.86B |
| Lotus Pharmaceutical | 56.28B |
| Oneness Biotech | 30.90B |
| Polaris Group | 27.31B |
| Center Laboratories | 26.39B |
| Pegavision | 24.38B |